AbbVie Total Liabilities 2012-2026 | ABBV

AbbVie total liabilities for the quarter ending March 31, 2026 were $136.497B, a 0.62% decline year-over-year.

  • AbbVie total liabilities for 2024 were $131.797B, a 6.02% increase from 2023.
  • AbbVie total liabilities for 2023 were $124.314B, a 2.3% increase from 2022.
  • AbbVie total liabilities for 2022 were $121.518B, a 7.3% decline from 2021.

AbbVie Total Liabilities 2012-2026 | ABBV

  • AbbVie total liabilities for 2024 were $131.797B, a 6.02% increase from 2023.
  • AbbVie total liabilities for 2023 were $124.314B, a 2.3% increase from 2022.
  • AbbVie total liabilities for 2022 were $121.518B, a 7.3% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B